source
- European pharma CEOs warn of biotech decline as R&D share drops to 31% and call for faster trials and stronger IP protectionNine leading European pharma board chairs issued an open letter warning that Europe is losing its biotech edge. They note that Europe's share of global pharma R&D fell from 43% in 1990 to 31% toda…
- China’s $522 bn biotech push fuels US competition and partnership opportunitiesChinese biotech is entering a rapid growth phase, with the government’s new five-year plan targeting about $522 billion in revenue by 2030 and aiming for at least 25% of first-in-class drugs worldw…